Genomics Revolution in Cancer

Masterclass held 19 January 2025Published 6 September 2026

Dr. Shrinidhi Nathany, a molecular haematology and oncology consultant at Fortis Memorial Research Institute, Gurgaon, explains how genomic sequencing has replaced appearance-based biopsy readings as the basis for classifying and treating cancer. The session covers hereditary cancer risk testing, precision and targeted therapy, pharmacogenomics, liquid biopsy, gene therapy and the practical realities of cost and access to genomic testing today.